Schwannomatosis: a genetic and epidemiological study

Area of Science:

• Genetics
• Epidemiology
• Oncology

Background:

• Schwannomatosis is a dominantly inherited nerve tumor condition with diagnostic overlap with neurofibromatosis-2 (NF2).
• The epidemiology of schwannomatosis remains poorly understood, necessitating accurate incidence and prevalence data.

Purpose of the Study:

• To determine the birth incidence and prevalence of schwannomatosis, accounting for diagnostic overlap with NF2.
• To investigate the genetic basis and clinical presentation differences between schwannomatosis and NF2.

Main Methods:

• Ascertainment of schwannomatosis and NF2 cases from the Manchester region and across the UK.
• Calculation of point prevalence and birth incidence using regional birth statistics.
• Genetic analysis of *NF2*, *LZTR1*, and *SMARCB1* genes from patient DNA samples.

Main Results:

• Regional prevalence: Schwannomatosis 1 in 126,315; NF2 1 in 50,500. Birth incidence: Schwannomatosis 1 in 68,956; NF2 1 in 27,956.
• Misdiagnosis impacts at least 9% of schwannomatosis cases due to mosaic NF2, and 1-2% due to *LZTR1*-associated schwannomatosis.
• Schwannomatosis patients present with more spinal/peripheral schwannomas and pain; life expectancy is significantly better (76.9 years) than in NF2 (66.2 years).

Conclusions:

• Schwannomatosis has a lower birth incidence and prevalence than NF2.
• Accurate diagnosis is crucial due to significant overlap and misdiagnosis rates, particularly with mosaic NF2.
• Distinct clinical features and improved life expectancy characterize schwannomatosis compared to NF2.